In recent years, precision oncology has emerged as a groundbreaking approach to cancer treatment, leveraging genetic and molecular information to tailor therapies to individual patients. Valued at approximately USD 107.82 billion in 2023, the global precision oncology market is projected to reach USD 250.11 billion by 2032, growing at a …
Read More »